Privium Fund Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
9,320
+1,810
| +24% | +$252K | 0.28% | 28 |
|
|
2025
Q1 | $1.35M | Sell |
7,510
-1,740
| -19% | -$314K | 0.35% | 28 |
|
|
2024
Q4 | $1.45M | Buy |
9,250
+2,900
| +46% | +$454K | 0.33% | 29 |
|
|
2024
Q3 | $1.16M | Sell |
6,350
-70
| -1% | -$12.7K | 0.29% | 33 |
|
|
2024
Q2 | $1.14M | Buy |
6,420
+1,920
| +43% | +$341K | 0.29% | 41 |
|
|
2024
Q1 | $801K | Sell |
4,500
-2,110
| -32% | -$375K | 0.21% | 51 |
|
|
2023
Q4 | $826K | Buy |
6,610
+1,400
| +27% | +$175K | 0.23% | 48 |
|
|
2023
Q3 | $604K | Hold |
5,210
| – | – | 0.18% | 53 |
|
|
2023
Q2 | $603K | Sell |
5,210
-3,470
| -40% | -$401K | 0.17% | 54 |
|
|
2023
Q1 | $695K | Hold |
8,680
| – | – | 0.23% | 46 |
|
|
2022
Q4 | $694K | Buy |
8,680
+1,418
| +20% | +$113K | 0.26% | 42 |
|
|
2022
Q3 | $512K | Buy |
7,262
+2,782
| +62% | +$196K | 0.19% | 59 |
|
|
2022
Q2 | $294K | Buy |
4,480
+480
| +12% | +$31.5K | 0.1% | 76 |
|
|
2022
Q1 | $266K | Buy |
+4,000
| New | +$266K | 0.06% | 111 |
|